Entero Therapeutics Inc. (ENTO) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear

Entero Therapeutics Inc.

NASDAQ: ENTO · Real-Time Price · USD
3.15
0.85 (36.96%)
At close: Sep 12, 2025, 3:59 PM
3.05
-3.17%
After-hours: Sep 12, 2025, 05:47 PM EDT

Entero Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-998.27K -1.26M -12.24M -2.58M -8.81M 5.57M -4.1M -3.43M -4.19M -4.07M -3.99K 4.39M -5.41M -9.63M -11.17M -30.4M -9.28K -7.69K
Depreciation & Amortization
n/a n/a n/a 1.34K 35.32K 12.29K 7.32K 7.32K 7.32K 7.32K 7.32 22.29K 30.82K 30.5K 132.35K 138K 133.88 132.91
Stock-Based Compensation
n/a n/a 44.66K 183.65K 131.89K 271.36K 126.12K 263.33K 292.7K 358.32K 165.85 91.64K 374.91 337.23 186.00 182.41 314.06 1.81K
Other Working Capital
-423.55K 423.55K 655.49K 374.22K -70.7K -74.89 519.54 752.11 -29.72 1.02K -742.11 -8.25M 234.03K 308.63K 14.09M 288.24K -311.41 601.41
Other Non-Cash Items
1.26M 126.75K 10.62M 17.33K 786.53K 4.81M 33.59K 92.09K 15.81K 15.53K -1.14K 641.16K 286.75K -640.16K 22.32M -13.36M 2.99K 49.08
Deferred Income Tax
n/a n/a n/a n/a 4.26M -14.86M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Change in Working Capital
-314.23K 314.23K 1.4M 530.17K 147.86K 451.15K 494.53K -259.8K 1.11M 843.91K -643.14 -8.76M 416.81K 1.35M -1.39M 14.23M 222.49 619.01
Operating Cash Flow
-54.88K -818.63K -171.52K -1.85M -3.45M -3.75M -3.44M -3.33M -2.76M -2.85M -5.59K -4.25M -4.59M -7.91M -5.86M -15.73M -5.62K -5.07K
Capital Expenditures
n/a n/a n/a n/a n/a -4 -500K n/a n/a n/a n/a n/a n/a n/a 1.96K -10.25M -73.93 n/a
Cash Acquisitions
n/a n/a n/a n/a n/a 88.17K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a n/a n/a -500 n/a n/a n/a n/a n/a n/a n/a -10.25K 9M n/a n/a
Investing Cash Flow
n/a n/a n/a n/a n/a 88.17K -500 n/a n/a n/a n/a n/a n/a n/a 1.96K -1.25M -73.93 n/a
Debt Repayment
n/a 700K -31.8K -177.56K -209.21K -226.01K n/a -153.48K -226.91K -223.1K n/a -161.91K -240.86K -238.47K 641.24K -139.57K -207.51K -205.32K
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
-163.43K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
163.43K n/a -1.73M 1.73M 36.00 9.00 -5.95M 3.71M 2.24M 301.00 -1.86M -2.64M n/a -2.41M n/a 8.33M 9.82M -4.91M
Financial Cash Flow
n/a 700K -31.8K 1.55M 681.42K 3.38M 4.36M 5.39M 1.93M 3.55M 5.52K 4.77M 76.38K 5.37M 6.82M 16.11M 1.78K 11.05K
Net Cash Flow
-54.88K -118.64K -203.32K -295.69K -2.77M -279.86K 419.44K 2.06M -828.38K 701.53K -294.1 502K -4.54M -2.55M 1.04M 7.2M -3.95K 5.96K
Free Cash Flow
-54.88K -818.63K -171.52K -1.85M -3.45M -3.75M -3.94M -3.33M -2.76M -2.85M -5.59K -4.25M -4.59M -7.91M -5.86M -25.98M -5.7K -5.07K